Development of a brief treatment instrument for routine clinical use with methadone maintenance treatment clients: The methadone treatment index

Substance Use and Misuse

Volumn 43, Issue 11, 2008, Pages 1666-1680

  Deering, Daryle E ^a   Sellman, J Douglas ^a   Adamson, Simon J ^a   Horn, Jacqueline ^a   Frampton, Christopher M A ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

Clinical settings; Methadone treatment; Methadone Treatment Index; Routine measurement treatment outcome

Indexed keywords

METHADONE;

ADULT; ALCOHOLISM; ARTICLE; BEHAVIOR; CANNABIS ADDICTION; CLINICAL ASSESSMENT TOOL; DRUG DEPENDENCE; FEMALE; HEALTH; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; METHADONE TREATMENT; METHADONE TREATMENT INDEX; PRIORITY JOURNAL; SOCIAL STATUS; SUBSTANCE ABUSE; ADDICTION; DRUG DEPENDENCE TREATMENT; EVALUATION; HEALTH CARE QUALITY; METHODOLOGY; NEW ZEALAND; OUTCOME ASSESSMENT; PSYCHOMETRY; QUESTIONNAIRE;

FEMALE; HUMANS; MALE; METHADONE; NEW ZEALAND; OUTCOME ASSESSMENT (HEALTH CARE); PSYCHOMETRICS; QUALITY OF HEALTH CARE; QUESTIONNAIRES; SUBSTANCE ABUSE TREATMENT CENTERS; SUBSTANCE-RELATED DISORDERS;

EID: 50649113472     PISSN: 10826084     EISSN: 15322491     Source Type: Journal    
DOI: 10.1080/10826080802116098     Document Type: Article

References (39)

1. Adamson, S. (2003). Naturalistic Treatment Outcome Project (NTOP). Final Report to the Alcohol Advisory Council of New Zealand. Wellington, New Zealand.
2. American Psychiatric Association. (1994). Diagnostic and Statistical Manual of Mental Disorders (4th ed.). Washington, DC: American Psychiatric Association.
3. Anastasi, A. Psychological Testing (1961). (2nd ed.). New York: The MacMillian Co.
4. Ball, J. C., Ross, A. (1991). The effectiveness of methadone maintenance treatment: patients, programmes, services and outcomes. New York: Springer-Verlag.
5. Beck, A. T., Steer, R. A. (1987). Manual for the revised Beck Depression Inventory. San Antonio: The Psychological Corporation.
6. Bell, J. (1998). Delivering effective methadone treatment. In: Ward, J., Mattick, R. P., Hall, W., eds. Opioid maintenance treatment and other opioid replacement therapies. London: Harwood Academic Publishers.
7. Cohen, J. W. (1988). Statistical power analysis for the behavioural sciences (2nd ed.). Hillsdale, New Jersey: Lawrence Erlbaum Associates.
8. Darke, S. (1998). The effectiveness of methadone maintenance treatment 3: moderators of treatment outcome. In: Ward, J., Mattick, R. P., Hall, W., eds. Opioid maintenance treatment and other opioid replacement therapies. London: Harwood Academic Publishers.
9. Darke, S., Hall, W., Ross, M., Wodak, A. (1992). Benzodiazepine use and HIV risk-taking among injecting drug users. Drug Alcohol Dependence 31:31-36.
10. Darke, S., Hall W., Wodak, A., Heather, N., Ward, J. (1992). Development and validation of a multi-dimensional instrument for assessing outcome of treatment among opiate users: The Opiate Treatment Index. British Journal of Addictions 87:733-742.
11. Darke, S., Swift, W., Hall, W. (1994). Prevalence, severity and correlates of psychological morbidity among methadone maintenance clients. Addiction 89:211-217.
12. Darke, S., Swift, W., Hall, W., Ross, M. (1993). Drug use, HIV risk-taking and psychosocial correlates of benzodiazepine use among methadone maintenance clients. Drug Alcohol Dependence 34:67-70.
13. Darke, S., Ward, J., Hall, W., Heather, N., Wodak, A. (1991). Opiate Treatment Index (OTI) Manual (Technical Report No. 11). Sydney, Australia: National Drug and Alcohol Research Centre, University of New South Wales.
14. Darke, S., Ward, J., Zador, D., Swift, G. (1991). A scale for estimating the health status of opioid users. British Journal of Addictions 86:1317-1322.
15. Deering, D.E., Sellman, J.D. (1996). An inter-relater reliability study of the OTI. Drug Alcohol Review 15:57-63.
16. Derogatis, L. R., Lipman, R. S., Rickels, K., Uhlenhuth, E. H., Covi, L. (1974). The Hopkins Symptom Checklist (HSCL): a self-report inventory. Behavioral Science 19:1-15.
17. Dinwiddie, S. H., Reich, T., Cloninger, C. R. (1992). Psychiatric co-morbidity and suicidality among intravenous drug users. Journal of Clinical Psychiatry 53:364-369.
18. Epstein, D. H., Preston, K. L. (2003). Does cannabis use predict poor outcome for heroin dependent patients on maintenance treatment? Past findings and more evidence against. Addiction 98:269-279.
19. Fleiss, J. L. (1991). Statistical methods for rates and proportions. New York: John Wiley.
20. Gerstein, D. R., Harwood, H. J., eds. (1990). Treating drug problems, Volume 1: A study of the evolution, financing and effectiveness of public and private drug treatment systems. Washington, DC: National Academy Press.
21. Institute of Medicine. (1990). Broadening the Base of Treatment for Alcohol Problems. Washington, DC: National Academy Press.
22. Green, D. E., Walkey, F. H., McCormick, I. A., Taylor, A. J. (1988). Development and evaluation of a 21-item version of the Hopkins Symptom Checklist with New Zealand and United States respondents. Australian Journal of Psychology 40:61-70.
23. Landis, J. R., Koch, G. G. (1977). The measurement of observer agreement for categorical data models. Biometrics 33:159-174.
24. MacEwan, I. (1995). Upper limits for responsible drinking. tWellington: Alcohol Advisory Council of New Zealand.
25. Marsden, J., Gossop, M., Stewart, D., Best, D., Farrell, M., Lehmann, P., Edwards, C., Strang, J. (1998). The Maudsley Addiction Profile (MAP): a brief instrument for assessing treatment outcome. Addiction 93:1857-1868.
26. McLellan, A. T., Kushner, H., Metzger, D., Peters, R., Smith, I., Grissom, G., Pettinati, H., Argeriou, M. (1992). The fifth edition of the Addiction Severity Index: historical critique and normative data. Journal of Substance Abuse Treatment 9:199-213.
27. McLellan, A. T., Lewis, D. C., O'Brien, C. P., Kleber, H. D. (2000). Drug dependence, a chronic medical illness: implications for treatment, insurance, and outcomes evaluation. Journal of the American Medical Association, 284:1689-1685.
28. Ministry of Health. (2003). Opioid Substitution Treatment: New Zealand Practice Guidelines. Wellington: Ministry of Health.
29. Ministry of Health. (2001). A National Strategic Framework for Alcohol and Drug Services. Wellington: Ministry of Health, Wellington.
30. Moos, R. H., Finney, J. W., Cronkite, R. C. (1990). Alcoholism treatment: context, process and outcome. Oxford: Oxford University Press.
31. Richter, K. P., Ahluwalia, J. S. (2000). A case for addressing cigarette use in methadone and other opioid treatment programmes. Journal of Addictive Diseases 19:35-52.
32. Rounsaville, B. J., Kleber, H. D. (1985). Untreated opiate addicts. How do they differ from those seeking treatment? Archives of General Psychiatry 42:1072-1077.
33. Rounsaville, B. J., Weissman, M. M., Kleber, H., Wilber, C. (1982). Heterogeneity of psychiatric diagnosis in treated opiate addicts. Archives of General Psychiatry 39:61-66.
34. Rush, B. (1996). Alcohol and other drug problems and treatment systems: a framework for research and development. Addiction 9:629-642.
35. Sellman, J. D. (2004, January). Methamphetamine use amongst the New Zealand alcohol and drug treatment population. Results from a national telephone survey 2003. Presentation to the Centre for Social and Health Outcomes Research and Evaluation (SHORE), Massey University: Auckland.
36. Spielberger, C. D., Gorsuch, F. L., Lushene, R., Vagg, P. R., Jacobs, G. A. (1983). Manual for the State-Trait Anxiety Inventory. Palo, California: Consulting Psychologists Press.
37. Stimson, G. V., Jones, S., Chalmers, C., Sullivan, D. (1998). A short questionnaire (IRQ) to assess injecting risk behaviour. Addiction 9:337-347.
38. Teesson, M., Clement, N., Copeland, J., Conroy, A., Reid, A. (2000). The measurement of outcome in alcohol and other drug treatment: a review of available instruments. Sydney: National Drug and Alcohol Research Centre, University of New South Wales.
39. Ward, J., Hall, W., Mattick, R. P. (1999). Role of maintenance treatment in opioid dependence (Seminar). The Lancet 353:221-226.